Mergers and acquisitions kept up their fast and furious pace in the third quarter of 2021. So says a recent M&A report from advisory firm Mertz & Taggart. “There were 44 total home health, hospice and home care transactions completed in the third quarter of 2021, up from the 41 deals that took place in the previous quarter,” the report highlights. “Over the past three years, the only quarter with more transactions was 2020 Q4.” Reasons for the activity include changes in legislative prospects for capital gains taxes; burned out agency owners looking to exit the market; and high hopes for the pending Home Health Value-Based Purchasing payment model, the firm says.
The slower home health sub-market saw a spike in deals in the third quarter, Mertz Taggart Managing Partner Cory Mertz says. The firm tracked at least 16 home health-related deals in Q3 2021, on par with Q2. The hospice market stayed hot with “at least 23 hospice-related deals in Q3 2021, up from 17 transactions in Q2,” the report notes. Don’t miss: “Of the 44 home health, hospice and home care transactions in Q3 2021, private equity buyers and their portfolio companies led the way with 25 deals. Public companies like LHC Group, Amedisys and others took part in at least 16 transactions,” the report recounts. The fourth quarter already is off and running as well. That includes a newly announced acquisition by PE firm Ridgemont Equity Partners, which has bought Spartanburg, South Carolina-based Agape Care Group for undisclosed terms from The Vistria Group. “Ridgemont has spent years exploring opportunities in the hospice sector and believes that Agape Care is in a position to meaningfully increase its geographic footprint with a focus on hospice and palliative care acquisitions across the Southeast,” Ridgemont partner Dan Harknett says in a release. Agape operates in South Carolina and Georgia.